Mankind Pharma board approves divestment of its stake in Broadway Hospitality Services

The board of Mankind Pharma at its meeting held on 11 July 2026, has inter-alia, considered and approved the:

1. proposal for divestment of 100% stake held in Broadway Hospitality Services (Broadway), a wholly owned subsidiary company; and
2. incorporation of a wholly owned subsidiary company in Netherlands (WOS) to act as a Special Purpose Vehicle for holding investments in R&D assets and business development activities focused on treatment of niche therapies.